Document is current

Any future updates will be listed below

Erratum to: Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study

Crossref DOI link: https://doi.org/10.1007/s40620-014-0128-2

Published Online: 2014-08-07

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark